Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

I certainly do think. Exactly that. But consider

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 401)
Posted On: 04/21/2021 12:42:14 PM
Posted By: bandg
Re: wildtp #69320
I certainly do think. Exactly that. But consider-you note that Remdesivir is being given WITH Brilicidin and then Remdesivir is being given AS the "placebo". IF one ASSUMES that Remdesivir has NO (or even very low) effect on the patients, then what WOULD be causing ANY AND ALL effects? It seems one MIGHT THEN ASSUME that the candidate drug (insert your favorite IPIX property HERE) IS causing any (MOST? ALL?) oberved effects?

As I said, assumption is often incorrect. But the fact is there will be a certain level of placebo effect. Unavoidable and often a statistically predictable value. Since, in this current Brilicidin, the SOC comparator being used is Remdesivir, and since Brilicidin is being given with Remdesivir in the treatment arm, if Remdesivir is increasingly viewed as relatively ineffective, the what might a person ASSUME TO BE the cause of any positive results that are seen? It seems that, IF one assumes Remdesivir is having little to no effect, then there is only one other thing it could be.

This possible view that Remdesivir has even less effectiveness than some previoiusly may have thought is not particularly good for the "blinding" of the study. But it doesn't seem like it will invalidate anything related to the study results either. My speculation is whether any perceived view of a possible loss of "blinding" (again, some speculation "someone" might jump to) might spur someone to do something sooner than they might otherwise have done. I know this is verbous and long but I hope what I'm saying is clear. Maybe this will make it more clear. GOOOO BRILICIDIN!!!!


(1)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us